Related Experiment Video
Updated: Feb 19, 2026

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates
Published on: May 10, 2022
Endocytosis of receptor tyrosine kinases is driven by monoubiquitylation, not polyubiquitylation
Yaron Mosesson1, Keren Shtiegman, Menachem Katz
1Department of Biological Regulation, The Weizmann Institute of Science, Rehovot 76100, Israel.
Abstract:
Growth factors stimulate specific receptor tyrosine kinases, but subsequent receptor endocytosis terminates signaling. The ubiquitin ligase c-Cbl targets epidermal growth factor receptors (EGFRs) to endocytosis by tagging them with multiple ubiquitin molecules. However, the type of ubiquitylation is unknown; whereas polyubiquitin chains signal proteasomal degradation, ubiquitin monomers control other processes. We report that in isolation c-Cbl mediates monoubiquitylation rather than polyubiquitylation of EGFRs. Consistent with the sufficiency of monoubiquitylation, when fused to the tail of EGFR, a single ubiquitin induces receptor endocytosis and degradation in cells. By using receptor and ubiquitin mutants, we infer that c-Cbl attaches a founder monoubiquitin to the kinase domain of EGFR and this is complemented by the conjugation of additional monoubiquitins. Hence, receptor tyrosine kinases are desensitized through conjugation of multiple monoubiquitins, which is distinct from polyubiquitin-dependent proteasomal degradation.
Insights
The ubiquitin ligase c-Cbl targets epidermal growth factor receptors (EGFRs) for endocytosis via monoubiquitylation, not polyubiquitylation. This process desensitizes receptor tyrosine kinases, distinct from proteasomal degradation pathways.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Growth factors bind receptor tyrosine kinases (RTKs), initiating signaling cascades.
- Receptor endocytosis typically terminates RTK signaling.
- The ubiquitin ligase c-Cbl mediates epidermal growth factor receptor (EGFR) endocytosis through ubiquitylation.
Purpose of the Study:
- To elucidate the specific type of ubiquitylation mediated by c-Cbl on EGFRs.
- To determine the role of different ubiquitylation types in RTK signaling termination.
- To investigate the mechanism by which c-Cbl regulates EGFR endocytosis and desensitization.
Main Methods:
- In vitro ubiquitylation assays using c-Cbl and EGFR.
- Generation and utilization of receptor and ubiquitin mutants.
- Cell-based assays to assess EGFR endocytosis and degradation.
Main Results:
- c-Cbl mediates monoubiquitylation, not polyubiquitylation, of EGFRs in isolation.
- A single ubiquitin modification is sufficient to induce EGFR endocytosis and degradation.
- c-Cbl attaches a founder monoubiquitin to the EGFR kinase domain, followed by additional monoubiquitins.
Conclusions:
- RTK desensitization is achieved through the conjugation of multiple monoubiquitins, a mechanism distinct from polyubiquitin-dependent proteasomal degradation.
- Monoubiquitylation by c-Cbl is the key event for EGFR endocytosis and signaling termination.
- This finding reveals a novel regulatory pathway for RTK signaling control.
Related Concept Videos
Receptor-mediated Endocytosis
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Receptor Tyrosine Kinases
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

